These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1191358)

  • 1. Proceedings: Evidence of cell-mediated immunity to collagen in patients with progressive systemic sclerosis.
    Stuart JM; Postlethwaite AE; Kang AH
    Arthritis Rheum; 1975; 18(5):525-6. PubMed ID: 1191358
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis.
    Stuart JM; Postlethwaite AE; Kang AH
    J Lab Clin Med; 1976 Oct; 88(4):601-7. PubMed ID: 965811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular immune phenomenon in scleroderma].
    Fritz J; Sandhofer M
    Dermatologica; 1977; 154(3):129-37. PubMed ID: 852625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immune response to collagen I in patients with systemic scleroderma].
    Vladimirtsev VA; Avdeeva ZhI; Guseva NG; Rassokhina II; Anan'eva LP
    Vopr Revm; 1982; (1):33-8. PubMed ID: 6178214
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopathogenesis of scleroderma--evolving concepts.
    Sapadin AN; Esser AC; Fleischmajer R
    Mt Sinai J Med; 2001; 68(4-5):233-42. PubMed ID: 11514910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electron microscopy study of pathological collagen fibril formation in systemic scleroderma].
    Ptashekas RS; Vaĭtkene DI
    Arkh Patol; 1984; 46(7):49-54. PubMed ID: 6477175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of progressive systemic sclerosis.
    Postlethwaite AE; Kang AH
    J Lab Clin Med; 1984 Apr; 103(4):506-10. PubMed ID: 6607964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiopathology of scleroderma].
    Fleischmajer R; Perlish JS; Maquart FX; Kalis B
    Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte markers in patients with progressive systemic sclerosis.
    Czirják L; Dankó K; Sonkoly I; Bodolay E; Szegedi G
    Acta Med Hung; 1985; 42(3-4):109-14. PubMed ID: 2937012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of systemic scleroderma: immunological aspects].
    Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
    Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to collagen type I and fibronectin in patients with scleroderma systemic ].
    Taova MK; Kurdanov KA
    Klin Med (Mosk); 1996; 74(7):50-1. PubMed ID: 8992117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies.
    Czirják L; Surányi P; Dankó K; Szegedi G
    Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-collagen IV antibodies in patients with scleroderma and idiopathic Raynaud's phenomenon].
    Gabrielli A; Montroni M; Rupoli S; Caniglia ML; Danieli G
    Recenti Prog Med; 1985 Jan; 76(1):21-2. PubMed ID: 3991970
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothesis for the pathogenesis of systemic sclerosis.
    Furst DE; Clements PJ
    J Rheumatol Suppl; 1997 May; 48():53-7. PubMed ID: 9150119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The state of cellular immunity in patients with systemic scleroderma].
    Borisova AM; Stepanova EN; Burnaeva ZN
    Ter Arkh; 1987; 59(4):46-8. PubMed ID: 3590004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early immune events in scleroderma.
    Postlethwaite AE
    Rheum Dis Clin North Am; 1990 Feb; 16(1):125-39. PubMed ID: 2406803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen.
    McKown KM; Carbone LD; Bustillo J; Seyer JM; Kang AH; Postlethwaite AE
    Arthritis Rheum; 2000 May; 43(5):1054-61. PubMed ID: 10817559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.